BALANCE 1,5% GLUCOZA, 1,75 mmol/l calciu România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

balance 1,5% glucoza, 1,75 mmol/l calciu

fresenius medical care deutschland gmbh - germania - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala solutii hipertone

BALANCE 4,25% GLUCOZA, 1,75 mmol/l calciu România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

balance 4,25% glucoza, 1,75 mmol/l calciu

fresenius medical care deutschland gmbh - germania - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala solutii hipertone

BALANCE 2,3% GLUCOZA, 1,75 mmol/l calciu România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

balance 2,3% glucoza, 1,75 mmol/l calciu

fresenius medical care deutschland gmbh - germania - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala solutii hipertone

FLUDEOXYGLUCOSE BIONT 200-1300 MBQ/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fludeoxyglucose biont 200-1300 mbq/ml

biont a.s. - republica slovaca - fludeoxiglucoza (18f) - sol inj. - 200-1300mbq/ml - preparate pentru detectarea tumorilor alte radiofarmaceutice pt. detectarea tumorilor

FLUDEOXYGLUCOSE BIONT 200-2200 MBQ/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fludeoxyglucose biont 200-2200 mbq/ml

biont a.s. - republica slovaca - fludeoxiglucoza (18f) - sol. inj. - 200-1300mbq/ml - preparate pentru detectarea tumorilor alte radiofarmaceutice pt. detectarea tumorilor

Comirnaty Uniunea Europeană - română - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Nespo Uniunea Europeană - română - EMA (European Medicines Agency)

nespo

dompé biotec s.p.a. - darbepoetină alfa - kidney failure, chronic; anemia; cancer - preparate antianemice - tratamentul anemiei simptomatice asociate cu insuficiența renală cronică (crf) la adulți și copii. tratamentul anemiei simptomatice la pacienții adulți cu cancer non-mieloid administrează chimioterapie.

CAMERA TERMOSTATATA, TIP TC 20000 România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

camera termostatata, tip tc 20000

sc caloris group sa -

CAMERA TERMOSTATATA, TIP TC 3000 România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

camera termostatata, tip tc 3000

sc caloris group sa -

CAMERA ENDOSCOPICA EROND (1CCD) România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

camera endoscopica erond (1ccd)

sc cattus srl -